Abstract:
PURPOSE: A hybridoma and a monoclonal antibody secreted by the hybridoma for assaying Lily symptomless virus (LSV) is provided. The monoclonal antibody is designed to specifically react with the LSV using the cell fusion technique and can be used in assaying the virus infection in a large scale of sample. CONSTITUTION: A hybridoma secreting a monoclonal antibody to the LSV is prepared by comprising the following steps of: purifying the LSV; designing, screening and cloning the hybridoma exhibiting genetic properties of a lymphocyte (BALB/c) and a tumor cell (NS-1) by fusing the lymphocyte which is obtained in an animal immune reaction and the tumor cell; purifying the monoclonal antibody for assaying the LSV; identifying the isotype of the antibody by ELISA; identifying that the monoclonal antibody can recognize the epitope of the LSV by dot immunobinding assay (DIBA); assaying the LSV infection. The prepared hybridoma 1G6-B1 line is deposited in Korean Cell Line Bank, under the deposit number KCLRF-BP-00021.